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Background: Nosocomial outbreaks of multidrug-resistant Acinetobacter baumannii are of worldwide concern.
Using pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and multiple locus variable number
tandem repeat sequence (VNTR) analysis (MLVA), the present work examines the genetic diversity of the endemic and
epidemic A. baumannii clones isolated in a single hospital over a twelve-year period.
Results: PFGE analysis of 405 A. baumannii-calcoaceticus complex isolates detected 15 A. baumannii endemic/epidemic
PFGE types (EE1 to EE15) that grouped into five clusters: EE1-EE8, EE9, EE10, EE11 and EE12-EE15. The MLST sequence
type (ST) distributions were: international clone II (ST-2) 60%, international clone III (ST-3) 26.7%, ST-15 6.7%, and ST-80
6.7%. MLVA-8Orsay returned 17 allelic profiles. The large (L) VNTR marker profiles were fully concordant with the detected
STs, and concordant with 14 up to 15 PFGE types. Imipenem resistance was detected in five PFGE types; the prevalence
of the blaOXA-58-like and blaOXA-40-like genes was 60% and 40% respectively.
Conclusions: PFGE proved to be a vital tool for analysis of the temporal and spatial distribution of the clones. MLST
and the VNTR L-markers grouped the isolates into clonal clusters. The wide diversity of MLVA small (S)-markers,
however, did not permit clustering. The present results demonstrate the persistence of several endemic PFGE types
in the hospital, the involvement of some of them in outbreaks, and the inter hospital transmission of extensively
drug-resistant ST-15 and ST-80.
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The bacterium Acinetobacter baumannii is very tolerant
to desiccation and has developed resistance against
many of the antimicrobial agents in common use [1].
Both these features render it ideally suited to survive in the
hospital environment, and invest it with the power to cause
important nosocomial outbreaks [2]. Multidrug-resistant
(MDR) A. baumannii infection is a worldwide health
problem that has a negative impact on the morbidity
and the mortality of the affected patients [3,4]. The epi-
demiological study of MDR A. baumannii outbreaks is
essential if they are to be ended and their recurrence* Correspondence: pvillalon@isciii.es
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unless otherwise stated.prevented. Clonal analysis of the strains involved is a
vital part of these studies [5]. This can be undertaken
via genotyping techniques such as pulsed-field gel elec-
trophoresis (PFGE) [6,7], multilocus sequence typing
(MLST) [7-9], and multiple locus variable number tan-
dem repeat sequence (VNTR) analysis (MLVA) [10-12].
Genotyping provides information concerning outbreaks;
e.g., the genetic diversity of clones, their temporal and
spatial distribution, their implication on endemic or epi-
demic events, the acquisition source of the bacteria, as
well as the number of affected patients; that is basic for
preventive and control measures to be implemented.
A previous study of A. baumannii isolates from Spanish
hospitals [13] showed the predominance of international
clone II (sequence type 2 [ST-2]). Two novel clones were
also detected - ST-79 and ST-80 - as well as international. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cluded international clone III (ST-3), ST-15 and ST-32.
The aim of the present work was to study the endemic
and epidemic clones of A. baumannii in a not previously
studied single hospital over a long period, and to compare
them, using the aforementioned genotyping methods, with
other nosocomial clones circulating in Spain.
Results
PFGE analysis
PFGE analysis of the 405 A. baumannii-calcoaceticus
complex isolates returned 120 different PFGE types.
Among these, 105 PFGE types (covering 174 isolates)
were considered sporadic given their wide genetic dis-
parity and small number of isolates (<5). Fifteen PFGE
types, however, covering 231 A. baumannii isolates, were
considered endemic or epidemic, and selected for fur-
ther study.
Figure 1 shows the PFGE genetic similarity dendo-
gram. The PFGE types were numbered EE1 to EE15.
The Hunter-Gaston diversity index (HGDI) [14] calcu-
lated for the PFGE technique with respect to the further-
examined 231 isolates was 0.880 (Table 1). The genetic
similarity range for their 15 PFGE types was 60.4 – 100%.Figure 1 Genetic diversity of endemic and epidemic Acinetobacter ba
PFGE types, sequence types (ST), MLVA-8Orsay complexes, repeat number fo
and involvement in outbreaks. Pairs EE4-EE4* and EE10-EE10* had the same P
shows the 75% genetic similarity cut-off. Abbreviations: 2 F, second floor;
SR, surgery room; ER, emergency room; OC, out-patient clinic consultation
PFGE types detected in other hospitals.Five clusters (75% cut-off) were observed; their genetic
similarity values were EE1-EE8 (78.8 – 100%), EE9-Ab9
(94.1%), EE10-EE10* (100%), EE11-Ab54 (89.7%), and
EE12-EE15 (83.7 – 89.7%). Figure 2 shows the temporal
and spatial distribution of the endemic/epidemic clones.
Acinetobacter baumannii epidemic sequence types
For each gene, the number of alleles and polymorphic
sites (in parenthesis) were: cpn60 4 (6), fusA 4 (3), gltA 3
(2), pyrG 2 (1), recA 3 (4), rplB 4 (3), and rpoB 4 (2).
Four different STs were detected: ST-2, ST-3, ST-15 and
ST-80. The HGDI for the MLST technique was 0.655
(Table 1).
International clone II (ST-2) involved clusters EE1-EE8
and EE10 (Figure 1), and included 60% of the studied
PFGE types. International clone III (ST-3) involved clus-
ter EE12-EE15 and 26.7% of the PFGE types. ST-15 and
ST-80 were detected in clusters EE11 and EE9 respect-
ively, both representing 6.7% of the PFGE types.
Acinetobacter baumannii epidemic MLVA-8Orsay types
Seventeen MLVA-8Orsay allelic profiles were detected
among the 15 studied PFGE types since the pairs EE4-
EE4* and EE10-EE10* had different allelic profilesumannii clones. Left to right: PFGE genetic similarity dendogram,
r the eight VNTR markers, number of isolates, location in the hospital,
FGE type but different MLVA type. The broken line in the dendogram
3 F, third floor; 4 F, fourth floor; 5 F, fifth floor; ICU, intensive care unit;
room. Dash means lack of amplification. Ab9 and Ab54 are epidemic
Table 1 MLVA-8Orsay data and comparison of PFGE, MLST and MLVA discriminatory power in endemic and epidemic
Acinetobacter baumannii PFGE types
MLVA locus or Genotyping technique Repeat size (bp) No. of repeats mode
(no. of repeats range)
Alleles or no. of genotypes HGDIa CI (95%)b
Abaum_3530 60 6 (6 – 7) 2 0.502 (0.499, 0.508)
Abaum_3002 57 8 (7 – 8) 2 0.496 (0.482, 0.510)
Abaum_2240 99 4 (2 – 5) 3 0.345 (0.275, 0.415)
Abaum_1988 77-80 2 (2 – 3) 2 0.641 (0.617, 0.665)
Abaum_0826 9 13 (9 – 20) 9 0.833 (0.813, 0.853)
Abaum_0845 7 44 (2 – 44) 9 0.819 (0.795, 0.843)
Abaum_2396 6 12 (10 – 29) 9 0.807 (0.777, 0.837)
Abaum_3468 6 9 (8 – 11) 4 0.658 (0.625, 0.691)
PFGE 15 0.880 (0.858, 0.902)
MLST 4 0.655 (0.624, 0.686)
MLVA-8 17 0.883 (0.863, 0.903)
aHunter-Gaston diversity index (HGDI) calculations were performed taking into account all 231 isolates in the studied 15 PFGE types, except for Abaum_0845
(N = 210), owing to the lack of amplification in EE14 and EE15.
bHGDI 95% confidence interval.
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technique, taking into account all the VNTR loci exam-
ined, was 0.883. The individual HGDI scores for these
markers ranged from 0.345 to 0.833. Microsatellites were
more diverse (0.658 ≤HGDI ≤ 0.833) than minisatellites
(0.345 ≤HGDI ≤ 0.641). Assuming a 40% cut-off for
MLVA-8Orsay genetic similarity (data not shown), four
MLVA complexes were identified: A, B, C, and D. Figure 1
and Table 1 show the MLVA-8Orsay data. Figure 3 shows
the minimum spanning tree for MLVA-8Orsay clustering.
Amplification products were obtained for all VNTR
markers except for Abaum_0845 in EE14 and EE15. A
previously described, non-conserved 77–80 bp repeat
unit in the Abaum_1988 locus [11] was detected in all
PFGE types, instead of the 26 bp repeat unit described
by Pourcel [10].
Susceptibility to antimicrobial agents, β-lactamase genes,
and insertion sequences
The antimicrobial susceptibility rates recorded were
100% for colistin, 82.4% for sulbactam, 64.7% for imipe-
nem, 64.7% for meropenem, 35.3% for amikacin, 35.3%
for minocycline, 17.6% for doxycycline, and 17.6% for
trimethoprim-sulfamethoxazole. All isolates showed resist-
ance to mezlocillin, piperacillin, piperacillin-tazobactam,
cefotaxime, ceftazidime, cefepime, gentamicin, tobramycin,
tetracycline, ciprofloxacin, and levofloxacin.
All 15 PFGE types had an extensively drug-resistant
(XDR) phenotype involving non-susceptibility to ≥1
agent in all but ≤2 antimicrobial categories [15]. Resist-
ance to imipenem (MIC ≥4 μg/ml) was detected in five
of the PFGE types: EE1, EE9, EE10, EE11, and EE15.
Carbapenem hydrolyzing oxacillinase (CHO) genes
and metallobetalactamase (MBL) genes were sought inthe five PFGE types resistant to imipenem, as well as in
Ab9 and Ab54 (Table 2). EE1, EE11, EE15 and Ab54 car-
ried the CHO gene blaOXA-58-like, with ISAba2 and
ISAba3 upstream and downstream respectively. EE9,
EE10, and Ab9 carried the blaOXA-40-like gene. No MBL
genes were amplified. Acinetobacter-derived cephalos-
porinase (ADC) and OXA-51 genes were also sought
among the PFGE types with ST-80 or ST-15, and com-
pared to those of Ab9 and Ab54 (which respectively
show these STs). Pairs EE11-Ab54 and EE9-Ab9 had the
same pattern of ADC, OXA-51 and CHOs genes and as-
sociated insertion sequences (IS) (Table 2).
Discussion
This study includes all A. baumanni-calcoaceticus com-
plex isolates collected in a hospital during a twelve-year
period. The clonal analysis of these isolates identified 15
endemic A. baumannii PFGE types, four of which were
also epidemic because were involved in nosocomial out-
breaks. Three A. baumannii nosocomial outbreaks oc-
curred in the studied hospital between 1999 and 2010
(Figures 1 and 2). The first was in 1999–2000 in the
pneumology area on the hospital’s third floor. This af-
fected 20 patients and involved two PFGE types: EE1
and EE15. Both, EE1 and EE15 were first detected during
this outbreak and persisted endemically till 2001 on the
third floor. The second outbreak was in the ICU in
March 2007, with four patients affected. This was caused
by PFGE type EE13. This same PFGE type was found to
be endemic between 2005 and 2009 on the third, fourth,
and fifth floors of the hospital, and in the ICU, the emer-
gency room, and out-patient consultation rooms. The
third outbreak, from December 2009 to March 2010,
also involved the ICU and was caused by PFGE type
Figure 2 Distribution of endemic and epidemic Acinetobacter baumannii PFGE types. The top chart shows the temporal distribution of the
15 endemic and epidemic PFGE types, and the sequence types (ST). Vertical arrows indicate the nosocomial outbreaks. The bottom table shows
the detailed data of the temporal and spatial distribution of the PFGE types. Abreviations: 2 F, second floor; 3 F, third floor; 4 F, fourth floor; 5 F,
fifth floor; ICU, intensive care unit; SR, surgery room; ER, emergency room; OC; out-patient clinic consultation room.
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Figure 3 Minimum spanning tree showing MLVA clustering. Circles represent the different MLVA types, the size is proportional to the number
of isolates. The corresponding PFGE types are indicated inside the circles, the color indicates the sequence type (ST). The connecting lines indicate the
distance between MLVA types, coded according to the number of locus variants. Dotted lines group the four MLVA complexes A, B, C, and D.
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PFGE types (EE2-EE9, EE11, EE12, and EE14) were re-
sponsible for no epidemic event, but were found to be
endemic; i. e. they were isolated on several occasions in
different parts of the hospital environment. The tem-
poral distribution of the 15 PFGE types was variable; it
showed a range from one to six years, highlighting the
long persistence of EE9, EE13 and EE11 during four, five
and six years, respectively. The spatial distribution of the
15 PFGE types was universal in the hospital, although
third floor (113 isolates) and ICU (44 isolates) were the
most affected wards, probably due to the kind of activity
and patients cared in these areas. All but three PFGE
types -EE2, EE3, and EE10- were detected in the third
floor, and eight out of fifteen PFGE types were detectedTable 2 β-lactamase genes and associated insertion sequence
PFGE type MLST sequence type Acinetobacter-derived
cephalosporinase type
OX
EE1 2 Not typed No
EE10 2 Not typed No
EE10*a 2 Not typed No
EE15 3 Not typed No
EE9 80 ISAba1−ADC-1c OXA
Ab9b 80 ISAba1−ADC-1 OXA
EE11 15 ADC-2 ISA
Ab54b 15 ADC-2 ISA
aEE10 and EE10* had the same PFGE type but different MLVA type.
bAb9 and Ab54 were epidemic PFGE types detected in other hospitals.
cISAba1 was detected upstream of ADC-1.
dThe OXA-64/99/132 sequence was consistent with OXA-64, OXA-99 and OXA-132 [2
eISAba1 was detected upstream of OXA-64/99/132.
fISAba2 and ISAba3 were detected upstream and downstream of OXA-58 respective
gND: not detectable.in the ICU. The most ubiquitous PFGE types were EE8,
EE11 and EE13. Long persistence, wide distribution and
antimicrobial resistance are risk factors for new out-
breaks. Figure 2 shows the temporal and spatial distribu-
tion of the 15 endemic/epidemic PFGE types.
The MLST results correlated with PFGE clustering.
Most of the PFGE types (60%; clusters EE1-EE8 and
EE10) circulating in the hospital during the study period
were of sequence type ST-2 (or international clone II
[9]). The majority presence of this clone is usual for
Spanish hospitals [13], as in other Mediterranean coun-
tries [16], and indeed other parts of the world [17,18]. A
previous study [13] showed that the highly prevalent ST-
2 was detected on PFGE types that had very different
DNA band patterns. This diversity is also detected ins in A. baumannii with an imipenem MIC of >32 μg/ml




t typed ISAba2−OXA-58−ISAba3f NDg
t typed OXA-40 ND
t typed OXA-40 ND







Villalón et al. BMC Microbiology  (2015) 15:47 Page 6 of 9this study with the presence of ST-2 in clusters EE1-EE8
and EE10 -which showed only 65% genetic similarity-.
ST-3 (or international clone III [9], PFGE cluster EE12-
EE15), has been involved in many nosocomial outbreaks
around the world [19], and in the present study was the
second most common within PFGE types (26.7%). ST-15
(PFGE cluster EE11) and ST-80 (PFGE cluster EE9) were
the two least common (6.7%), although both have been
described as involved in outbreaks in other Spanish hos-
pitals. International clonal complex1/ST-81, and se-
quence types ST-79 and ST-32 were not detected in the
present study, but all are important nosocomial clones
previously detected in Spanish hospitals [13].
MLVA-8Orsay returned a perfect correlation between
the L marker allelic profiles and the ST results. There-
fore, MLVA-8Orsay L marker results correlate with PFGE
clustering. The same L marker allelic profiles (and there-
fore STs) were even seen for certain PFGE types in dif-
ferent clusters, e.g., L markers 7-7-4-3 (ST-2) in clusters
EE1-EE8 and EE10. The S marker allelic profiles showed
a wide diversity. As an example, the same PFGE type
can show different S marker allelic profiles over short
periods [10]. For instance, between 2000 and 2001, a
change in three S loci was recorded in PFGE type EE4
(recorded as types EE4 and EE4*; Figures 1, 2 and 3).
Similarly, over the space of just a few months between
2009 and 2010 - within the same outbreak - changes in
two S loci were recorded in PFGE type EE10 (recorded
as EE10 and EE10*; Figures 1, 2 and 3). In one of the lat-
ter loci (allele 0826), the change involved a remarkable
descent in the number of tandem repeats from 17 (in
EE10) to 9 (in EE10*). In fact, the diversity associated
with allele 0826 has led some authors [11] to exclude it
in the establishment of MLVA complexes. In the present
study, the variability associated with the S markers was
so great that it was not possible to define criteria for
establishing MLVA complexes, neither to apply criteria
defined by other authors [10,11]. The MLVA com-
plexes were therefore defined assuming a 40% genetic
similarity cut-off, and full correlation was also seen be-
tween the MLST and MLVA-8Orsay complexes, i.e., ST-
2 with A, ST-80 with B, ST-15 with C, and ST-3 with D
(Figures 1 and 3).
MLVA-8Orsay L markers are very useful for establishing
phylogenetic relationships because of their stability [10],
and reveal relationships similar to those provided by
MLST analysis [12,20]. To date, several criteria for the
formation of MLVA complexes using L and S markers
have been proposed for A. baumannii [10,11]. Agree-
ment has been achieved with the interpretation of L
markers but no consensus has been reached with respect
to S markers, −something already achieved for other
pathogens [21]- specifically with the maximum number
of allele and repeat differences that can be accepted tocluster different MLVA types into the same MLVA
complex.
The 15 studied PFGE types all showed XDR. Indeed,
three (EE1, EE10 and EE15) of the four PFGE types in-
volved in the three outbreaks described in the present
work, were also resistant to imipenem. Resistance is
common in A. baumannii nosocomial outbreaks since
resistant strains are selected for in hospital environ-
ments, especially in high risk areas such as ICUs [4,22].
Other PFGE types resistant to imipenem, endemic but
not involved in any outbreak, were detected in the
present study, such as EE9 and EE11. Both showed a
wide distribution across several areas of the hospital, and
were isolated over long time periods (Figures 1 and 2).
EE9 was isolated from 2005 to 2008 on the third, fourth,
and fifth floors, and EE11 was isolated over 2003–2007
and during 2009 from the same floors as EE9, in addition
to the ICU, emergency room, and out-patient clinic
consultation rooms.
The susceptibility and β-lactamase results fitted well
with the epidemiological data for Spain, where the resist-
ance of A. baumannii to carbapenems is basically due to
the activity of OXA-40 and OXA-58 [23]. OXA-23 activ-
ity has been commonly reported around the world, but
only recently reported for A. baumannii in Spain [24].
The idea that interhospital transmission of XDR A. bau-
mannii clones occurs is reinforced by the detection of a
common pattern for the ADC, OXA-51, and CHOs
genes, and their associated ISs, for example as seen in
PFGE type pairs EE11 and Ab54, and EE9 and Ab9.
Conclusions
The comparison of the three genotyping methods shows
that MLST is very useful in global A. baumannii clonal
studies, clustering the isolates into big clones. Though
laborious, PFGE provides essential information in local
studies of A. baumannii outbreaks. Currently, MLVA-
8Orsay L markers provide similar information than
MLST, but it has the drawback that no consensus has
been reached regarding the interpretation of S markers.
MLVA-8Orsay could be a better typing method than
PFGE for A. baumannii if new S markers were added to
MLVA panel and agreed criteria for MLVA clustering
were established.
In the present study, the most prevalent was inter-
national clone II (ST-2), followed by international clone
III (ST-3), ST-15 and ST-80. The period 1999–2004 was
characterized by the predominant presence of inter-
national clone II. The period 2005–2010, however, saw
diversification, with the increasing presence of inter-
national clone III (ST-3), ST-15 and ST-80. Extensively
drug-resistance was universal and the genes providing
resistance to carbapenems were blaOXA-58-like and
blaOXA-40-like. The finding of the same β–lactamase
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Ab54, suggests the interhospital transmission of the
XDR A. baumannii clones ST-80 and ST-15. Finally, this
study highlights that the endemic presence of extremely
resistant PFGE types poses a potential risk for future
outbreaks [25]. The present results also confirm the per-
sistence of fifteen endemic PFGE types in a tertiary care
hospital and the involvement of four of them in three
outbreaks.
Methods
PFGE-typed strains and study design
The bacteria examined were 405 not previously studied
A. baumannii-calcoaceticus complex isolates from a
285-bed public tertiary care hospital in the southeast of
Spain; all were collected over the period 1999–2010
(both sporadically and during epidemic situations) and
were sent to the Spanish National Center for Microbiol-
ogy for their molecular characterization. Table 3 shows
the distribution by year, sample type, and hospital ward
of isolation for all 405 isolates.
The clinical samples were taken as part of standard pa-
tient care and also for this purpose, the bacterial strains
were sent to a public national reference laboratory for
their clonal analysis. This study focused on bacteria and
no identifiable human data were used, therefore ethical
approval was exempted.
All the isolates were analyzed by PFGE. All distin-
guishable PFGE patterns were interpreted as different
PFGE types. Clustering was determined by using the
unweighted-pair group method with arithmetic averages
(UPGMA) and by using Dice’s coefficient. The tolerance
was set at 0.8% and the optimization at 1.5%. All calcula-
tions were performed by using InfoQuest software (AppliedTable 3 Distribution of the 405 Acinetobacter baumannii-calco
study period
Yeara 1999 (1/7) 2000 (28/52) 200
2005 (30/35) 2006 (35/46) 200
Type of samplea,b Respiratory (73/152) Wound (39/69) En
Urine (14/32) Blood (11/20) No
Hospital warda,b 3rd Floor: IMd (115/181) ICU (44/53)
4th Floor: IM, and General and
Digestive Surgery (21/49)
Out-patient consultat
5th Floor: IM (22/38) Emergency Room (9/





aIn parenthesis are indicated the number of endemic-epidemic A. baumannii isolate
bDistributions are ordered from most to least frequent in relation to the total numb
cTypes of environmental samples (N=55): not informed (n=16), nursing trolley (10),
monitor (3), closet (3), oxygen equipment (2), table (1).
dIM: Internal Medicine.Maths, Saint-Marten-Latem, Belgium). The PFGE types
that were suspected of being endemic or epidemic were se-
lected for further study. The selection criterion was based
on the number of isolates and the genetic similarity; i.e.,
PFGE types that had ≥5 isolates, and PFGE types that al-
though had <5 isolates showed ≥85% genetic similarity with
the former PFGE types. A cut-off of 75% was subsequently
chosen for clustering the selected PFGE types into big
clones. The member isolates (N = 231) were identified as A.
baumannii by blaOXA-51-like gene amplification [26], ana-
lyzed by MLST and MLVA, tested for antimicrobial suscep-
tibility, and examined for β-lactamase genes and their
commonly associated ISs. The origin of the selected isolates
was environmental (n = 52) and clinical (n = 179, one iso-
late per patient).
MLST and MLVA
MLST analysis was performed following the protocol of
the Institute Pasteur (www.pasteur.fr/recherche/geno-
pole/PF8/mlst/Abaumannii.html). The cpn60, fusA, gltA,
pyrG, recA, rplB and rpoB genes were amplified using
the PCR conditions described by Bartual [8], and then
sequenced. The primers used to amplify the genes were
those described in the above-mentioned protocol, except
the primers used for rpoB, which were those reported in
earlier work [13]. Each allelic profile was assigned a ST.
MLVA typing was performed using the MLVA-8Orsay
method [10], i.e., involving four L markers (Abaum_3530,
Abaum_3002, Abaum_2240, and Abaum_1988) with
large repeat units of ≥9 bp (minisatellites), and four
S markers (Abaum_0826, Abaum_0845, Abaum_2396,
and Abaum_3468) with small repeat units in the 2–8 bp
range (microsatellites). For each VNTR locus, the alleles
were sequenced and the length of the repeat andaceticus complex isolates recovered over the twelve-year
1 (14/18) 2002 (35/50) 2003 (22/37) 2004 (9/35)
7 (32/50) 2008 (9/23) 2009 (7/26) 2010 (9/26)
vironmentalc (52/55) Exudates colonization screening (34/51)




s in the total number of A. baumannii-calcoaceticus complex isolates.
er of isolates.
bed (6), door (4), telephone (4), electric panel (3), breathing equipment (3),
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Finder tool (http://tandem.bu.edu/trf/trf.html). The num-
ber of repeats was calculated by rounding up according to
Vergnaud [21]. MLVA clustering was represented using a
minimum spanning tree produced using InfoQuest soft-
ware (Applied Maths, Saint-Martens-Latem, Belgium).
The comparison of the discriminatory power of the
PFGE, MLST, and MLVA typing techniques was done
calculating the Hunter-Gaston diversity index (HGDI)
[14] with a 95% confidence interval [27]. The MLVA
polymorphism index was calculated for individual and
combined VNTR loci.
Antimicrobial susceptibility, β-lactamase genes and insertion
sequences
Susceptibility testing was performed using the Micro-
Scan NM31 microdilution method (Dade Behring, West
Sacramento, CA, USA). Disc diffusion was used to deter-
mine susceptibility to doxycycline, minocycline and colistin
(all from Oxoid, Basingstoke, Hants, UK). Imipenem sus-
ceptibility was confirmed using E-test strips (bioMérieux,
Marcy-l’Etoile, France). Results were interpreted using the
Clinical Laboratory Standards Institute criteria for Acineto-
bacter spp. The control strains used were E. coli ATCC
25922 and E. coli ATCC 35218.
Screening for the ADC genes [28], and the four CHO
genes [29] blaOXA-51-like, blaOXA-23-like, blaOXA-40-like, and
blaOXA-58-like, as well as their most commonly associated
ISs (ISAba1, ISAba2, ISAba3, ISAba4 and IS18), was
performed. Screening was also undertaken for the MBL
genes [30] blaIMP, blaVIM, blaSIM-1, blaGIM-1, blaSPM-1 and
blaNDM-1 [31]. The PCR methods used were those de-
scribed in previous work [23].
Sequencing analysis
Purification of the PCR products was performed using
the illustra™ ExoProStar™ 1-Step Kit (GE Healthcare, NJ,
USA). Sequencing was performed in a 3730XL sequen-
cer using the BigDye Terminator Cycle Sequencing Kit
v.3.1 (Applied Biosystems, Foster City, CA, USA). The
sequences were assembled using Lasergene SeqMan II
software (DNA Star, Inc., Madison, Wis., USA).
Interhospital comparison of PFGE types
Two epidemic PFGE types, Ab54 and Ab9, that had
been previously described from other Spanish hospitals
[13], were added to the study. In 2003, Ab54 caused an
outbreak in the intensive care unit (ICU) of a hospital in
the Province of Almería (where the studied hospital is
also located). In 2005, Ab9 was involved in two out-
breaks in the ICUs of two different hospitals in the same
southwestern province of Spain (Badajoz). Ab54 was in-
cluded to the study for comparison with EE11 since both
shared ST-15. Ab9 was included for comparison withEE9 since both share ST-80. The interhospital comparison
of these four PFGE types included PFGE, MLST, and
MLVA typing; as well as the analysis of ADC, OXA-51,
CHO, MBL genes and associated ISs.
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